Addex Shareholders Approve All Resolutions at Annual General Meeting

Addex Starts Phase 2 Clinical Study of ADX71149 for Epilepsy

Addex to Participate at the Benchmark Company Healthcare House Call Conference

Addex’s Dipraglurant Restores Synaptic Plasticity in Models of Dystonia

Addex Convenes Annual General Meeting 2021

Addex Reports Q1 2021 Financial Results and Provides Corporate Update

Addex Therapeutics to Release Q1 2021 Financial Results and Host Conference Call on May 5, 2021

Addex Increases Issued Share Capital to Create Treasury Shares

Addex to Participate at the 4ᵗʰ Annual Neuroscience Innovation Forum

Addex to Present at the 20th Annual Needham Virtual Healthcare Conference